Skip to main content
Paul Shi

Paul Shi

Assoc. Director of Computational Biology, Amgen
Dr. Paul (Weibing) Shi has over 20 years of experience in computational biology, bioinformatics, and biomarker analysis. As Scientific Associate Director at Amgen, he leads a team generating critical biomarker data and overseeing infrastructure projects and Omics platform development. His team leverages AI/ML technologies for biomarker data processing and predictive signature development, enhancing drug discovery and development. At Roche and other renowned institutions, Dr. Shi developed bioinformatics workflows and managed large-scale NGS projects. Passionate about inclusivity, he champions the EPR (Encourage, Praise, and Recognize) approach to empower teams. Dr. Shi has authored over 20 scientific publications and is a certified SAFe® 5 Agilist.